Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Joy Martinez"'
Autor:
Marcal Yll-Pico, Yoonsuh Park, Joy Martinez, Angelina Iniguez, Mindy Kha, Taehyun Kim, Leonard Medrano, Vu H. Nguyen, Teodora Kaltcheva, Shannon Dempsey, Flavia Chiuppesi, Felix Wussow, Don J. Diamond
Publikováno v:
npj Vaccines, Vol 9, Iss 1, Pp 1-11 (2024)
Abstract Human cytomegalovirus (CMV) is the most common infectious cause of complications post-transplantation, while a CMV vaccine for transplant recipients has yet to be licensed. Triplex, a multiantigen Modified Vaccinia Ankara (MVA)-vectored CMV
Externí odkaz:
https://doaj.org/article/7de9db78369f482a9f2be1a9c25e1148
Autor:
Flavia Chiuppesi, Vu H. Nguyen, Yoonsuh Park, Heidi Contreras, Veronica Karpinski, Katelyn Faircloth, Jenny Nguyen, Mindy Kha, Daisy Johnson, Joy Martinez, Angelina Iniguez, Qiao Zhou, Teodora Kaltcheva, Paul Frankel, Swagata Kar, Ankur Sharma, Hanne Andersen, Mark G. Lewis, Yuriy Shostak, Felix Wussow, Don J. Diamond
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-14 (2022)
Abstract Second-generation COVID-19 vaccines could contribute to establish protective immunity against SARS-CoV-2 and its emerging variants. We developed COH04S1, a synthetic multiantigen modified vaccinia Ankara-based SARS-CoV-2 vaccine that co-expr
Externí odkaz:
https://doaj.org/article/759512ebd0914a7ebf39111c72a326f2
Autor:
Felix Wussow, Mindy Kha, Katelyn Faircloth, Vu H. Nguyen, Angelina Iniguez, Joy Martinez, Yoonsuh Park, Jenny Nguyen, Swagata Kar, Hanne Andersen, Mark G. Lewis, Flavia Chiuppesi, Don J. Diamond
Publikováno v:
iScience, Vol 25, Iss 6, Pp 104457- (2022)
Summary: COVID-19 vaccine efficacy is threatened by emerging SARS-CoV-2 variants of concern (VOC) with the capacity to evade protective neutralizing antibody responses. We recently developed clinical vaccine candidate COH04S1, a synthetic modified va
Externí odkaz:
https://doaj.org/article/a76f6bba437449628feb349c980b165d
Autor:
Flavia Chiuppesi, Marcela d’Alincourt Salazar, Heidi Contreras, Vu H. Nguyen, Joy Martinez, Yoonsuh Park, Jenny Nguyen, Mindy Kha, Angelina Iniguez, Qiao Zhou, Teodora Kaltcheva, Roman Levytskyy, Nancy D. Ebelt, Tae Hyuk Kang, Xiwei Wu, Thomas F. Rogers, Edwin R. Manuel, Yuriy Shostak, Don J. Diamond, Felix Wussow
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
Chiuppesi et al. demonstrate the use of a synthetic poxvirus-based platform to rapidly generate multi-antigenic vaccine candidates expressing spike and nucleocapsid antigens of SARS-CoV-2. Immunization of mice stimulates potent antigen-specific humor
Externí odkaz:
https://doaj.org/article/df0cbf9ed7ce4cb899492b5771e12516
Autor:
Felix Wussow, Flavia Chiuppesi, Joy Martinez, John Campo, Erica Johnson, Christin Flechsig, Maegan Newell, Elaine Tran, Jose Ortiz, Corinna La Rosa, Andreas Herrmann, Jeff Longmate, Rana Chakraborty, Peter A Barry, Don J Diamond
Publikováno v:
PLoS Pathogens, Vol 10, Iss 11, p e1004524 (2014)
Human Cytomegalovirus (HCMV) utilizes two different pathways for host cell entry. HCMV entry into fibroblasts requires glycoproteins gB and gH/gL, whereas HCMV entry into epithelial and endothelial cells (EC) requires an additional complex composed o
Externí odkaz:
https://doaj.org/article/db20909f284b4f04b1b9fa8d2626d9d3
Autor:
Paul Frankel, Don J. Diamond, Felix Wussow, Hanne Leth Andersen, Katelyn Faircloth, Yuriy Shostak, Veronica Karpinski, Mark G. Lewis, Angelina Iniguez, Vu H. Nguyen, Jenny Nguyen, Flavia Chiuppesi, Mindy Kha, Heidi Contreras, Ankur Sharma, Teodora Kaltcheva, Joy Martinez, Daisy Johnson, Swagata Kar, Qiao Zhou, Yoonsuh Park
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-14 (2022)
NPJ Vaccines
bioRxiv
NPJ Vaccines
bioRxiv
Second-generation COVID-19 vaccines could contribute to establish protective immunity against SARS-CoV-2 and its emerging variants. We developed COH04S1, a synthetic multiantigen modified vaccinia Ankara-based SARS-CoV-2 vaccine that co-expresses spi
Autor:
Felix Wussow, Edwin R. Manuel, Soojin Park, Marcela d'Alincourt Salazar, Angelina Iniguez, Jenny Nguyen, Heidi Contreras, Vu Q. Nguyen, Teodora Kaltcheva, Xiwei Wu, Don J. Diamond, Thomas F. Rogers, Nancy D. Ebelt, Flavia Chiuppesi, Joy Martinez, Tae Kang, Qiao Zhou, Mindy Kha, Roman Levytskyy, Yuriy Shostak
Publikováno v:
Research Square
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We developed a novel vaccine platform based on a unique three-plasmid system to efficiently generate rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71b84c3b7ee339cc8d3fddd6880ed668
https://doi.org/10.21203/rs.3.rs-40198/v1
https://doi.org/10.21203/rs.3.rs-40198/v1
Autor:
Joy Martinez, Heidi Contreras, Edwin R. Manuel, Tae Hyuk Kang, Vu H. Nguyen, Teodora Kaltcheva, Mindy Kha, Qiao Zhou, Xiwei Wu, Don J. Diamond, Yuriy Shostak, Flavia Chiuppesi, Felix Wussow, Angelina Iniguez, Roman Levytskyy, Marcela d'Alincourt Salazar, Nancy D. Ebelt, Jenny Nguyen, Thomas F. Rogers, Yoonsuh Park
Publikováno v:
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
Nature Communications, Vol 11, Iss 1, Pp 1-16 (2020)
Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We demonstrate the construction of a vaccine platform based on a unique three-plasmid system to efficien
Autor:
Flavia Chiuppesi, Marcela d’Alincourt Salazar, Heidi Contreras, Vu H Nguyen, Joy Martinez, Soojin Park, Jenny Nguyen, Mindy Kha, Angelina Iniguez, Qiao Zhou, Teodora Kaltcheva, Roman Levytskyy, Nancy D Ebelt, Tae Hyuk Kang, Xiwei Wu, Thomas Rogers, Edwin R Manuel, Yuriy Shostak, Don J Diamond, Felix Wussow
Publikováno v:
bioRxiv
Modified Vaccinia Ankara (MVA) is a highly attenuated poxvirus vector that is widely used to develop vaccines for infectious diseases and cancer. We developed a novel vaccine platform based on a unique three-plasmid system to efficiently generate rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8bdbd37d619a1484a5494083c2b8609c
https://doi.org/10.1101/2020.07.01.183236
https://doi.org/10.1101/2020.07.01.183236
Autor:
Zhuo Meng, Mindy Kha, Jenny Nguyen, Flavia Chiuppesi, Don J. Diamond, Felix Wussow, Corinna La Rosa, Heidi Contreras, Angelina Iniguez, Teodora Kaltcheva, Joy Martinez, Soojin Park
Publikováno v:
Journal of Virology. 93
As human cytomegalovirus (HCMV) is a common cause of disease in newborns and transplant recipients, developing an HCMV vaccine is considered a major public health priority. Yet an HCMV vaccine candidate remains elusive. Although the precise HCMV immu